DEVELOPMENT OF A NOVEL BIOMATERIAL FOR BONE TISSUE ENGINEERING. Tissue engineering of bone is emerging as a viable therapy for treating large defects in load-bearing bone. We wish to develop methods for combining novel heparan sulphate molecules (known to deliver growth factors to cell surfaces and thereby cause changes in bone cell phenotype) with load-bearing, macro-porous, biodegradable mineral/polymer biomaterials. Through the study of release profiles, protein adsorption and cell responses ....DEVELOPMENT OF A NOVEL BIOMATERIAL FOR BONE TISSUE ENGINEERING. Tissue engineering of bone is emerging as a viable therapy for treating large defects in load-bearing bone. We wish to develop methods for combining novel heparan sulphate molecules (known to deliver growth factors to cell surfaces and thereby cause changes in bone cell phenotype) with load-bearing, macro-porous, biodegradable mineral/polymer biomaterials. Through the study of release profiles, protein adsorption and cell responses to these derivatised biomaterials, a novel approach to bone replacement materials can be developed.Read moreRead less
Targeted growth factor delivery using natural polysaccharide materials for bone regeneration. This proposal addresses the core issue of nano-biomaterials capable of encouraging bone growth and providing better and more complete healing of bone fractures. Australia will benefit firstly through improved health outcomes by providing material-based solutions to address slow or non-healing fractures, which are increasingly prevalent in the aging population in Australia. This will have a further benef ....Targeted growth factor delivery using natural polysaccharide materials for bone regeneration. This proposal addresses the core issue of nano-biomaterials capable of encouraging bone growth and providing better and more complete healing of bone fractures. Australia will benefit firstly through improved health outcomes by providing material-based solutions to address slow or non-healing fractures, which are increasingly prevalent in the aging population in Australia. This will have a further benefit to the Australian economy improving the quality of life enabling people to work longer and reducing the need for further surgical intervention. This proposal will also have benefits to Australia through training future researchers in this field which will in turn provide economic growth through the development of Australian industries.Read moreRead less
Switching the light on cartilage repair. Osteoarthritis is a leading cause of pain and disability in adults and affects 15 per cent of the Australian population. This project will develop a revolutionary new approach to treat joint disorders using smart materials and stem cells. The novel materials and techniques developed will help Australia maintain its leading edge in biotechnology.
Industrial Transformation Training Centres - Grant ID: IC170100022
Funder
Australian Research Council
Funding Amount
$4,420,408.00
Summary
ARC Training Centre for Innovative BioEngineering. The ARC Training Centre for Musculoskeletal Biomedical Technologies will provide the next-generation of skilled graduates to overcome industry-focused challenges in musculoskeletal regeneration. The Centre expects to engineer a set of integrated technologies to personalise implants for the unique biological, physical and lifestyle characteristics of the recipient. Expected outcomes of the Centre include embedded bioelectronic sensors to assess a ....ARC Training Centre for Innovative BioEngineering. The ARC Training Centre for Musculoskeletal Biomedical Technologies will provide the next-generation of skilled graduates to overcome industry-focused challenges in musculoskeletal regeneration. The Centre expects to engineer a set of integrated technologies to personalise implants for the unique biological, physical and lifestyle characteristics of the recipient. Expected outcomes of the Centre include embedded bioelectronic sensors to assess and optimise the healing process. In addition, the Centre will produce data for use in deriving the next-generation of implants, giving rise to improved health outcomes, economic benefits, and a skilled workforce able to advance and perpetuate this important field.Read moreRead less
Engineering Articular Cartilage with Zonal Structure and Function. This project addresses the National Research Priority of Promoting and Maintaining Good Health and specifically the Priority Goal of Ageing well, ageing productively. Osteoarthritis, the most common cartilage-related disease, affects nearly 1.4 million Australians, resulting in 2 in 1000 Australians undergoing total joint replacement, annually. The incidence and impact of cartilage damage on the Australian health and economy is e ....Engineering Articular Cartilage with Zonal Structure and Function. This project addresses the National Research Priority of Promoting and Maintaining Good Health and specifically the Priority Goal of Ageing well, ageing productively. Osteoarthritis, the most common cartilage-related disease, affects nearly 1.4 million Australians, resulting in 2 in 1000 Australians undergoing total joint replacement, annually. The incidence and impact of cartilage damage on the Australian health and economy is expected to increase with the ageing population. This work leads to the development of a novel cartilage engineering technology platform that addresses Frontier Technologies and will thus provide the foundation for translation of this technology to the international marketplace. Read moreRead less
Miniaturised biosensors with high selectivity . This project aims to develop a technological platform for the fabrication of miniaturised and flexible sensors that enable the quantitative detection of important bioactive compounds such as fatty acids and biogenic amines. By utilising multi-enzymatic reactions in solid phase and engineering task-specific inks, chemiresistive sensors will be printed seamlessly as a whole. The sensors will respond to complex target biomolecules via a series of enzy ....Miniaturised biosensors with high selectivity . This project aims to develop a technological platform for the fabrication of miniaturised and flexible sensors that enable the quantitative detection of important bioactive compounds such as fatty acids and biogenic amines. By utilising multi-enzymatic reactions in solid phase and engineering task-specific inks, chemiresistive sensors will be printed seamlessly as a whole. The sensors will respond to complex target biomolecules via a series of enzymatic reactions through which the analyte will convert to much simpler, reactive and hence measurable molecules. This project will enable to design miniaturised sensors for point-of-care detection of biomolecules that cannot be yet evaluated by the end users.Read moreRead less
Tissue Engineering the Meniscus: Combining Novel Biomimetic Hybrid Scaffolds with Adult Stem Cells. Development of a meniscal implant ex vivo will provide significant health and economic benefits, given that worldwide, millions of people annually suffer from meniscus damage or loss. We believe that a tissue engineered meniscus, composed of a novel biomimetic scaffold which guides the differentiation of mesenchymal stem cells in a novel bioreactor will provide a solution to the problem of donor ....Tissue Engineering the Meniscus: Combining Novel Biomimetic Hybrid Scaffolds with Adult Stem Cells. Development of a meniscal implant ex vivo will provide significant health and economic benefits, given that worldwide, millions of people annually suffer from meniscus damage or loss. We believe that a tissue engineered meniscus, composed of a novel biomimetic scaffold which guides the differentiation of mesenchymal stem cells in a novel bioreactor will provide a solution to the problem of donor scarcity in meniscal repair. Success in this project will lead directly to large-animal studies and clinical trials. The training of four early careeer researchers involved in this project will also be of significant benefit to the Australian Tissue Engineering and Biomaterials community.Read moreRead less
Pancreatic Differentiation of Cord Blood Stem Cells using Smart Surfaces. Cord blood cells obtained at the time of delivery of a baby are a valuable resource that have the potential to develop into many cell types. This Project entails attaching stem cells derived from cord blood to appropriate 3 dimensional smart surfaces, and examining the ability of such cells to develop into insulin-producing cells. An understanding of how to coax stem cells, seeded on to smart surfaces, to develop into ma ....Pancreatic Differentiation of Cord Blood Stem Cells using Smart Surfaces. Cord blood cells obtained at the time of delivery of a baby are a valuable resource that have the potential to develop into many cell types. This Project entails attaching stem cells derived from cord blood to appropriate 3 dimensional smart surfaces, and examining the ability of such cells to develop into insulin-producing cells. An understanding of how to coax stem cells, seeded on to smart surfaces, to develop into mature cells with different functions will enhance our ability to understand how cells develop. As well, it enhance the potential usefulness of cord blood for research purposes. Read moreRead less
The Scale-up and Evaluation of a Novel Dense Gas Technology Platform for the Production of Particles for Aerosol Drug Delivery. This project provides a unique opportunity to develop an Australian-invented technology in particle engineering, enabling it to enter the international pharmaceutical market. This will enhance the growth of Australia's pharmaceutical research and development, and benefit the Australian pharmaceutical industry. The outcome will also contribute to improvements in the heal ....The Scale-up and Evaluation of a Novel Dense Gas Technology Platform for the Production of Particles for Aerosol Drug Delivery. This project provides a unique opportunity to develop an Australian-invented technology in particle engineering, enabling it to enter the international pharmaceutical market. This will enhance the growth of Australia's pharmaceutical research and development, and benefit the Australian pharmaceutical industry. The outcome will also contribute to improvements in the health and well-being of Australians. The research falls within the Designated National Research Priority of Frontier Technologies for Building and Transforming Australian Industries.Read moreRead less
NOVEL TRI-BLOCK CO-POLYMERS FOR CONTROLED RELEASE OF PROTEINS FOR OSTEOGENESIS. This research is being driven by the need for a scaffold for orthopaedic reconstruction that provides controlled release of growth factors to enable rapid healing. None of the current systems possess the required combination of properties to enable new tissue to regenerate rapidly. The aim of this project is to design a system for sustained drug release using block copolymer micelles to encapsulate growth factors and ....NOVEL TRI-BLOCK CO-POLYMERS FOR CONTROLED RELEASE OF PROTEINS FOR OSTEOGENESIS. This research is being driven by the need for a scaffold for orthopaedic reconstruction that provides controlled release of growth factors to enable rapid healing. None of the current systems possess the required combination of properties to enable new tissue to regenerate rapidly. The aim of this project is to design a system for sustained drug release using block copolymer micelles to encapsulate growth factors and then polymerising the micelles in a biodegradable polymer scaffold. This would enable local delivery of osteogenic growth factors to a bone defect.Read moreRead less